ANGPTL4 and metastatic melanoma: Most significant findings indicate that ANGPTL4 is associated with poorer overall survival (OS) in cancer patient except melanoma and metastatic melanoma which showed that ANGPTL4 is protective, however, this conflicts with previously reported literature that shows ANGPTL4 predicts worse prognosis in melanoma [55,56].